Cargando…

Studying neurological disorders using induced pluripotent stem cells and optogenetics

Detalles Bibliográficos
Autores principales:	Chin, Eunice W.M., Goh, Eyleen L.K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705766/ https://www.ncbi.nlm.nih.gov/pubmed/26807089 http://dx.doi.org/10.4103/1673-5374.169607

Ejemplares similares

Modulating neuronal plasticity with choline
por: Chin, Eunice W. M., et al.
Publicado: (2019)

Optogenetics for Retinal Disorders
por: Henriksen, Bradley S., et al.
Publicado: (2014)

An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
por: Su, Colin T. E., et al.
Publicado: (2015)

Induced pluripotent stem cells are induced pluripotent stem cell-like cells
por: Song, Liting, et al.
Publicado: (2015)

Optogenetic neuroregeneration
por: Janovjak, Harald, et al.
Publicado: (2021)

Visual prostheses, optogenetics, stem cell and gene therapies: splitting the cake
por: Barriga-Rivera, Alejandro, et al.
Publicado: (2018)

Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research
por: Mummery, Christine L.
Publicado: (2018)

From channelrhodopsins to optogenetics
por: Hegemann, Peter, et al.
Publicado: (2013)

Prospects for the Use of Induced Pluripotent Stem Cells in Animal Conservation and Environmental Protection
por: Stanton, Morgan M., et al.
Publicado: (2018)

Balancing serendipity and reproducibility: Pluripotent stem cells as experimental systems for intellectual and developmental disorders
por: Anderson, Nickesha C., et al.
Publicado: (2021)

Modeling Neurological Disorders by Human Induced Pluripotent Stem Cells
por: Kunkanjanawan, Tanut, et al.
Publicado: (2011)

Induced pluripotent stem cells for modeling and cell therapy of Parkinson's disease
por: Csöbönyeiová, Mária, et al.
Publicado: (2016)

Implications of Withaferin A in neurological disorders
por: Ram, Natasha, et al.
Publicado: (2020)

Exploring pre-degenerative alterations in humans using induced pluripotent stem cell-derived dopaminergic neurons
por: Bono, Federica, et al.
Publicado: (2017)

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research
por: Mascetti, Victoria L., et al.
Publicado: (2016)

The Tumorigenic Potential of Human Pluripotent Stem Cells
por: Lezmi, Elyad, et al.
Publicado: (2022)

History and current status of clinical studies using human pluripotent stem cells
por: Kobold, Sabine, et al.
Publicado: (2023)

Locus Coeruleus Optogenetic Modulation: Lessons Learned from Temporal Patterns
por: Harley, Carolyn W., et al.
Publicado: (2021)

Optogenetics: A new tool for cancer investigation and treatment
por: Alizadeh, Siamak, et al.
Publicado: (2022)

Neurological Dysfunction in Long COVID Should Not Be Labelled as Functional Neurological Disorder
por: Van der Feltz-Cornelis, Christina M., et al.
Publicado: (2023)

Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
por: Gruber, Amit, et al.
Publicado: (2022)

The utility of patient specific induced pluripotent stem cells for the modelling of Autistic Spectrum Disorders
por: Cocks, Graham, et al.
Publicado: (2013)

Repurposing niclosamide for the treatment of neurological disorders
por: Apolloni, Savina, et al.
Publicado: (2023)

The future of adenoassociated viral vectors for optogenetic peripheral nerve interfaces
por: Anderson, Hans E., et al.
Publicado: (2020)

Optogenetic‐mediated cardiovascular differentiation and patterning of human pluripotent stem cells
por: Hellwarth, Peter B., et al.
Publicado: (2021)

A Standard Nomenclature for Referencing and Authentication of Pluripotent Stem Cells
por: Kurtz, Andreas, et al.
Publicado: (2018)

Human induced pluripotent stem cell based in vitro models of the blood-brain barrier: the future standard?
por: Neuhaus, Winfried
Publicado: (2017)

N-acetyl proline-glycine-proline: implications for neurological disorders
por: Hill, Jeff W., et al.
Publicado: (2016)

Using Cardiovascular Cells from Human Pluripotent Stem Cells for COVID-19 Research: Why the Heart Fails
por: Yiangou, Loukia, et al.
Publicado: (2020)

Early life stress-induced neuroinflammation and neurological disorders: a novel perspective for research
por: Catale, Clarissa, et al.
Publicado: (2022)

Correction to: Optogenetic Control of Human Induced Pluripotent Stem Cell‐Derived Cardiac Tissue Models
Publicado: (2023)

Patterning inconsistencies restrict the true potential of dopaminergic neurons derived from human induced pluripotent stem cells
por: Mahajani, Sameehan, et al.
Publicado: (2020)

Induced pluripotent stem cells for defining Parkinsonian patient subtypes: a further step toward precision medicine
por: Bono, Federica, et al.
Publicado: (2021)

Novel pluripotent stem cell lines for enriched grafting in Parkinson’s disease
por: Cota-Coronado, Agustin, et al.
Publicado: (2019)

The Use of Pluripotent Stem Cell for Personalized Cell Therapies against Neurological Disorders
por: Ha, Hye-Yeong, et al.
Publicado: (2011)

A variety of photoreceptors and the frontiers of optogenetics
por: Tokutomi, Satoru, et al.
Publicado: (2022)

Turning Potential Into Action: Using Pluripotent Stem Cells to Understand Heart Development and Function in Health and Disease
por: Fonoudi, Hananeh, et al.
Publicado: (2017)

Induced pluripotent stem cells in the study of neurological diseases
por: Saporta, Mario A, et al.
Publicado: (2011)

Pluripotent stem cell derived inhibitory interneurons – principles and applications in health and disease
por: Keefe, Francesca, et al.
Publicado: (2019)

Programmable macromolecule-based RNA-targeting therapies to treat human neurological disorders
por: Morelli, Kathryn H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cc2gb6b6r4pj1bohptl4io8qqq